Leukaemia Busters Scientists Make Research Breakthrough
Leukaemia Busters scientists working in The Simon Flavell Leukaemia Research Laboratory at Southampton General Hospital have made a breakthrough discovery on how to increase the potency of immunotoxin treatment by over one million-fold for certain types of leukaemia and lymphoma
Read more about our research breakthrough
Genetically Engineered Antibodies and Immunotoxins
Leukaemia Busters funded scientists working in both Italy and the UK under the coordination and management of the charity’s Scientific Directors Office are designing and producing the next generation of antibody-based drugs for the treatment of leukaemia patients.
Read more about genetically engineered antibodies and immunotoxins
The Role of Innate Immunity in Killing Leukaemia Cells
Leukaemia Busters funded scientists have discovered that the patients own innate immunity cooperates with a class of antibody drug termed an immunotoxin resulting in the more effective killing of target leukaemia cells.
Read more about the role of innate immunity in killing leukaemia cells
New Antibody Discovery Programme
The science team based at the charity’s own Clinical Trials Support Unit (CTSU) are conducting work that is designed to produce and identify new antibodies that are the most effective at killing leukaemia cells.
Read more about the new antibody discovery programme